Literature DB >> 27898609

Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies.

Erin E Nichols, Ann Richmond, Anthony B Daniels.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27898609     DOI： 10.1097/IIO.0000000000000160

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  8 in total

1.  ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report.

Authors:  Inta Jaunalksne; Linda Brokāne; Donatas Petroška; Agnija Rasa; Pēteris Alberts
Journal:  Am J Ophthalmol Case Rep       Date:  2020-01-31

Review 2.  Retinal Pigment Epithelium Adenoma and Adenocarcinoma: A Review.

Authors:  Janani Sreenivasan; Pukhraj Rishi; Kalpita Das; Subramanian Krishnakumar; Jyotirmay Biswas
Journal:  Ocul Oncol Pathol       Date:  2020-12-22

3.  Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.

Authors:  Rachel E Doherty; Helen E Bryant; Manoj K Valluru; Ian G Rennie; Karen Sisley
Journal:  Cancers (Basel)       Date:  2019-08-30       Impact factor: 6.639

Review 4.  The premise of personalized immunotherapy for cancer dormancy.

Authors:  Masoud H Manjili
Journal:  Oncogene       Date:  2020-04-22       Impact factor: 9.867

Review 5.  Role of Natural Killer Cells in Uveal Melanoma.

Authors:  Asad Javed; Mohammed Milhem
Journal:  Cancers (Basel)       Date:  2020-12-09       Impact factor: 6.639

Review 6.  The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.

Authors:  Anna Hagström; Ruba Kal Omar; Pete A Williams; Gustav Stålhammar
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

Review 7.  New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes.

Authors:  Lingwen Gu; Guofeng Ma; Cui Li; Jing Lin; Guiqiu Zhao
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

8.  Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.

Authors:  Amy C Schefler; Alison Skalet; Scott Cn Oliver; John Mason; Anthony B Daniels; Katherina M Alsina; Kristen M Plasseraud; Federico A Monzon; Brian Firestone
Journal:  Melanoma Manag       Date:  2020-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.